ArticleEuropean urology focus2017
Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.
Article in European urology focus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 69 citations in OpenAlex.
- MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort.Journal of the National Cancer Center · 2026Article
- Artificial intelligence in digital pathology diagnosis and analysis: technologies, challenges, and future prospects.Military Medical Research · 2026Review
- Enhancing deep learning interpretability for hand-crafted feature-guided histologic image classification via weak-to-strong generalization.Journal of medical imaging (Bellingham, Wash.) · 2026Article
- The state of the art in artificial intelligence and digital pathology in prostate cancer.Nature reviews. Urology · 2026Review
- Prognostic value of nuclear features based on tumor-associated collagen signatures in breast cancer.NPJ breast cancer · 2025Article
- AI powered quantification of nuclear morphology in cancers enables prediction of genome instability and prognosis.NPJ precision oncology · 2024Article
- Harnessing artificial intelligence for prostate cancer management.Cell reports. Medicine · 2024Review
- Optimization of whole slide imaging scan settings for computer vision using human lung cancer tissue.PloS one · 2024Article
- Nuclei instance segmentation from histopathology images using Bayesian dropout based deep learning.BMC medical imaging · 2023Article
- Artificial intelligence in diagnostic pathology.Diagnostic pathology · 2023Review
- Nondestructive 3D pathology with analysis of nuclear features for prostate cancer risk assessment.The Journal of pathology · 2023Article
- Article
- Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology.BMC bioinformatics · 2023Article
- Applications of discriminative and deep learning feature extraction methods for whole slide image analysis: A survey.Journal of pathology informatics · 2023Review
- Article
- Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer.Frontiers in oncology · 2023Article
- Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.NPJ precision oncology · 2022Article
- Computerized spermatogenesis staging (CSS) of mouse testis sections via quantitative histomorphological analysis.Medical image analysis · 2021Article
- Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma.The Journal of clinical investigation · 2021Article
- Feature-driven local cell graph (FLocK): New computational pathology-based descriptors for prognosis of lung cancer and HPV status of oropharyngeal cancers.Medical image analysis · 2021Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundGleason scoring represents the standard for diagnosis of prostate cancer (PCa) and assessment of prognosis following radical prostatectomy (RP), but it does not account for patterns in neighboring normal-appearing benign fields that may be predictive of disease recurrence.
objectiveTo investigate (1) whether computer-extracted image features within tumor-adjacent benign regions on digital pathology images could predict recurrence in PCa patients after surgery and (2) whether a tumor plus adjacent benign signature (TABS) could better predict recurrence compared with Gleason score or features from benign or cancerous regions alone. DESIGN, SETTING, AND
participantsWe studied 140 tissue microarray cores (0.6mm each) from 70 PCa patients following surgery between 2000 and 2004 with up to 14 yr of follow-up. Overall, 22 patients experienced recurrence (biochemical [prostate-specific antigen], local, or distant recurrence and cancer death) and 48 did not.
interventionRP was performed in all patients. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The top 10 features identified as most predictive of recurrence within both the benign and cancerous regions were combined into a 10-feature signature (TABS). Computer-extracted nuclear shape and architectural features from cancerous regions, adjacent benign fields, and TABS were evaluated via random forest classification accuracy and Kaplan-Meier survival analysis. RESULTS AND LIMITATIONS: Tumor-adjacent benign field features were predictive of recurrence (area under the receiver operating characteristic curve [AUC]: 0.72). Tumor-field nuclear shape descriptors and benign-field local nuclear arrangement were the predominant features found for TABS (AUC: 0.77). Combining TABS with Gleason sum further improved identification of recurrence (AUC: 0.81). All experiments were performed using threefold cross-validation without independent test set validation.
conclusionsComputer-extracted nuclear features within cancerous and benign regions predict recurrence following RP. Furthermore, TABS was shown to provide added value to common predictors including Gleason sum and Kattan and Stephenson nomograms. PATIENT SUMMARY: Future studies may benefit from evaluation of benign regions proximal to the tumor on surgically excised prostate cancer tissue for assessing risk of disease recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.